Dots

2,360 views 19 slides Apr 18, 2012
Slide 1
Slide 1 of 19
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19

About This Presentation

Lecture By Dr.sati Moh'd Saleh
Fever Consultant


Slide Content

Dr. Satti M. Saleh Chief of Infectious Diseases Department MGH Director of IC Unit Meeqat General hospital CBAHI IC TEAM Member Medical Director Meeqat General Hospital W HO DOTs Strategy To Stop TB

History * Mycobacterium tuberculosis * MoTT * 24/3/1882 (Robert Koch) * 1993 (WHO – International Emergency) * 2000 ( Global partenership (STOP TB)) * DOT strategy * DOTS strategy * 2006 ( THE STOP TB STRATEGY )

CLINICAL SYNDROMS Primary TB ( 1 st Exposure) * Laten TB * Reactivation TB * Pulmonary TB * Extra pulmonary TB

DIAGNOSIS : AFB stain * Culture LJmedia Bactec * Molecular Method PCR Species determination Drug resistant mutation Typing * Others

BASIC CONTROL Detection of cases * Treatment (DOT) * INH Prophylaxis for high risk * Contact investigation * Isolation

Standardized short-course anti-TB treatment (SCC) given under direct and supportive observation (DOT).  1- INH 5mg /kg 2- RMP 10mg/kg 3- PZA 20-25mg/kg 4- ETM 15-25mg/kg 4 Drugs for 1 st 2 months 1st 2 Drugs for 2 nd 4 months

Isolation AIRBORNE Negative pressure HEPA filters HEPA mask Special mask for patient Pulmonary TB S+A Till sputum Negative

DRUG RESISTANT TB Mono resistant ( 1 drug) * Poly Resistant ( ~ 1 not MDR) * MDR (INH + RIF) * Extensively resistant (XDR – all 1 st line)

Other drugs 1- Amikacine 2- Kanamycine 3- Thiacetazone 4-Quinilone 5- cycloserine 6-clofazemine

TREATMENT O F LATENT INFECTION * Tuberculin test * PPD + ve * PPD - ve (2 step testing) * ( Avoid misclassification )

INDICATION HIV ≥ 5mm * Immunosuppressive drugs ≥ 5mm * Close contact of TB patient ≥ 5mm Fibrotic lesion on CXR ≥ 5mm 2years ~10mm > Recently infected person * High risk medical conditions ~10mm * Low risk ~ 15mm

DOTS STRATEGY - Detect smear + ve case & reporting - Observation of therapy( DOTs ) - Treatment monitoring ( recording, reporting assessment ) - - Short course (Drug Supply) - Government & non – government commitment

STOP TB STRATEGY (2006 – 2015 ) * DOTs * TB + HIV * Health System support * Engage all health care provider * Empower people with TB & community *Enable & promote research

Standardized recording and reporting Helps to keep track of each individual patient and to monitor overall programme performance

Sustained political and financial commitment. TB can be cured and the epidemic reversed if adequate resources and administrative support for TB control are provided
Tags